Cancer Survivor Heading To Space

It’s so great to see cancer survivors following their dreams! Isn’t it? Fans of The Voice on NBC and regular readers of this blog will already know that a former leukemia patient, Andrew Marshall, did quite well this season. He survived all the initial rounds on the popular singing competition – battles, knockouts, etc. –…… Continue reading Cancer Survivor Heading To Space

Cutaneous Lymphoma Annual Conference June 18-19

Registration is open for the Cutaneous Lymphoma Foundation’s (CLF) Virtual 2021 Annual Conference, June 18-19. To be clear, the annual conference is real, but it’s being delivered and attended online, i.e. in the virtual world. LOL If you or a loved one are affected by any of the cutaneous lymphomas or lymphomas with expression in…… Continue reading Cutaneous Lymphoma Annual Conference June 18-19

National Cancer Survivor Month 2021

Here we are in June already and National Cancer Survivor Month. It’s time to celebrate, folks!! According to the American Cancer Society, there are some 16.9 million people living with cancer in the U.S. That’s a LOT of celebrating! Whether you’ve just been diagnosed, are in the middle of chemo, receive doses of radiation daily,…… Continue reading National Cancer Survivor Month 2021

Lacutamab Clinical Trial for Certain CTCL Patients

Innate Pharma has recently announced phase 2 of a clinical trial dubbed TELLOMAK regarding the investigative drug lacutamab (IPH4102), an anti-KIR3DL2 monoclonal antibody, alone or in combination with chemo. The focus of this study is the treatment of patients with the rare cutaneous t-cell lymphoma (CTCL) Mycosis Fungoides and it’s systemic comparable Sézary Syndrome. The…… Continue reading Lacutamab Clinical Trial for Certain CTCL Patients